EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 3.0

Efficacy and Safety of Adjunctive Therapy Using Single High-Dose S-Ketamine Infusion for Fibromyalgia: A Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Study Protocol

Niti Shrestha iD, Minying Liu, Shaoning Niu, Hao Cheng, Yongxing Sun, Shenghui Mei iD, Fang Luo iD

Journal of Pain Research · 2026-05 · Volume 19 · 1-11

DOI: 10.2147/jpr.s598907 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Journal of Pain Research, 2026-05. Verfasst von Niti Shrestha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Intensive Care, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

adjunctive therapyblinded-endpointesketaminefibromyalgia

Autor:innen und Institutionen

  • Department of Anesthesia and Intensive Care, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
  • Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Department of Anesthesiology, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Department of Anesthesiology, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University, Beijing, People's Republic of China.

ORCID-Profile: Niti Shrestha, Shenghui Mei, Fang Luo

Zitieren

APA

Shrestha, N., Liu, M., Niu, S., Cheng, H., Sun, Y., Mei, S., & Luo, F. (2026). Efficacy and Safety of Adjunctive Therapy Using Single High-Dose S-Ketamine Infusion for Fibromyalgia: A Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Study Protocol. Journal of Pain Research, Volume 19, 1-11. https://doi.org/10.2147/jpr.s598907

Vancouver

Shrestha N, Liu M, Niu S, Cheng H, Sun Y, Mei S, et al. Efficacy and Safety of Adjunctive Therapy Using Single High-Dose S-Ketamine Infusion for Fibromyalgia: A Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Study Protocol. Journal of Pain Research. 2026;Volume 19:1-11. doi:10.2147/jpr.s598907

BibTeX
@article{Shrestha2026,
  author = {Shrestha, Niti and Liu, Minying and Niu, Shaoning and Cheng, Hao and Sun, Yongxing and Mei, Shenghui and Luo, Fang},
  title = {Efficacy and Safety of Adjunctive Therapy Using Single High-Dose S-Ketamine Infusion for Fibromyalgia: A Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Study Protocol},
  journal = {Journal of Pain Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--11},
  doi = {10.2147/jpr.s598907}
}
Kostenlos starten →